abrdn Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

abrdn Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$14.8M	Sell	131,045 -3,184	-2%	-$356K	0.05%	154
2017 Q1	$13.4M	Sell	134,229 -9,398	-7%	-$1M	0.04%	152
2016 Q4	$15.4M	Sell	143,627 -40,021	-22%	-$4.68M	0.05%	147
2016 Q3	$22.9M	Buy	183,648 +35,387	+24%	+$4.18M	0.09%	139
2016 Q2	$15.8M	Buy	148,261 +49,762	+51%	+$5.78M	0.07%	129
2016 Q1	$11.3M	Buy	+98,499	New	+$11.6M	0.05%	140

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

abrdn Investment Management's CBPO Position: Q2 2017 in Review

abrdn Investment Management reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 2.4% in Q2 2017, selling an estimated $356K and leaving 131,045 shares worth $14.8M. The position accounts for 0.05% of the portfolio, ranked #154.

abrdn Investment Management first reported a position in CBPO in Q1 2016 and has held it in 6 quarters since. The position peaked at $22.9M in Q3 2016. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

abrdn Investment Management held 131,045 shares of China Biologic Products Holdings, Inc. worth $14.8M as of Q2 2017.
abrdn Investment Management sold 3,184 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $356K.
China Biologic Products Holdings, Inc. made up 0.05% of abrdn Investment Management's portfolio in Q2 2017, its #154 holding.
abrdn Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and has held it in 6 quarters since.
abrdn Investment Management's China Biologic Products Holdings, Inc. position peaked at $22.9M in Q3 2016.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.